Sun Pharma-Ranbaxy $4 Bn All-Stock Deal
  • Prabha Hedge
  • Apr 07 2014

April 7: Ranbaxy stock has been under severe stress today after Sun Pharma agreed to buy the company in a $4 billion all-stock deal. Ranbaxy investors will get 0.8 share in Sun Pharma for every one of their shares. The deal makes Sun the largest pharma company in India and gives it control over Ranbaxy's pipeline of generic products. Speaking to Bloomberg TV India the management also stressed that they see huge value for Ranbaxy shareholder.